Pricing
Login
Home
Charts
Search
Watchlist
Products

Medico Remedies Ltd

MEDICO
₹18.54-1.44%20 Nov 2026
Reports
Pharma Formulations

Medico Remedies Ltd

MEDICO
₹18.54
-1.44%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹154Cr
Close
Close Price
₹18.54
Industry
Industry
Pharma Formulations
PE
Price To Earnings
11.24
PS
Price To Sales
0.59
Revenue
Revenue
₹259Cr
Rev Gr TTM
Revenue Growth TTM
50.78%
PAT Gr TTM
PAT Growth TTM
20.09%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
304131393941385359576974
Growth YoY
Revenue Growth YoY%
-23.447.6-2.1-7.132.6-0.124.233.848.637.581.440.5
Expenses
ExpensesCr
273728373635355054506671
Operating Profit
Operating ProfitCr
353237334733
OPM
OPM%
9.211.29.16.27.916.17.45.27.412.64.84.3
Other Income
Other IncomeCr
010110121311
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
242246234833
Tax
TaxCr
111111111211
PAT
PATCr
132234233632
Growth YoY
PAT Growth YoY%
-35.675.119.7-36.280.740.015.265.89.535.038.5-7.4
NPM
NPM%
4.97.55.13.96.610.54.84.94.910.33.63.2
EPS
EPS₹
0.20.40.20.20.30.50.20.30.30.70.30.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
304131393941385359576974
Growth YoY
Revenue Growth YoY%
-23.447.6-2.1-7.132.6-0.124.233.848.637.581.440.5
Expenses
ExpensesCr
273728373635355054506671
Operating Profit
Operating ProfitCr
353237334733
OPM
OPM%
9.211.29.16.27.916.17.45.27.412.64.84.3
Other Income
Other IncomeCr
010110121311
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
242246234833
Tax
TaxCr
111111111211
PAT
PATCr
132234233632
Growth YoY
PAT Growth YoY%
-35.675.119.7-36.280.740.015.265.89.535.038.5-7.4
NPM
NPM%
4.97.55.13.96.610.54.84.94.910.33.63.2
EPS
EPS₹
0.20.40.20.20.30.50.20.30.30.70.30.3

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6754619889122121140145151206259
Growth
Revenue Growth%
30.8-18.412.160.1-9.338.1-1.116.03.24.236.750.8
Expenses
ExpensesCr
6350589586117114131132136189241
Operating Profit
Operating ProfitCr
44333571013151718
OPM
OPM%
5.57.45.72.83.24.36.16.88.99.98.36.9
Other Income
Other IncomeCr
001221242366
Interest Expense
Interest ExpenseCr
112111111122
Depreciation
DepreciationCr
111222233333
PBT
PBTCr
22222461011141819
Tax
TaxCr
101111233355
PAT
PATCr
121223578101314
Growth
PAT Growth%
42.644.1-25.128.73.858.985.850.514.521.729.920.1
NPM
NPM%
1.73.02.01.61.82.14.05.25.76.76.35.3
EPS
EPS₹
3.55.10.20.20.20.30.60.91.01.21.61.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6754619889122121140145151206259
Growth
Revenue Growth%
30.8-18.412.160.1-9.338.1-1.116.03.24.236.750.8
Expenses
ExpensesCr
6350589586117114131132136189241
Operating Profit
Operating ProfitCr
44333571013151718
OPM
OPM%
5.57.45.72.83.24.36.16.88.99.98.36.9
Other Income
Other IncomeCr
001221242366
Interest Expense
Interest ExpenseCr
112111111122
Depreciation
DepreciationCr
111222233333
PBT
PBTCr
22222461011141819
Tax
TaxCr
101111233355
PAT
PATCr
121223578101314
Growth
PAT Growth%
42.644.1-25.128.73.858.985.850.514.521.729.920.1
NPM
NPM%
1.73.02.01.61.82.14.05.25.76.76.35.3
EPS
EPS₹
3.55.10.20.20.20.30.60.91.01.21.61.6
Sales CAGR
1 Year37%
3 Years14%
5 Years11%
TTM51%
EBITDA CAGR
1 Year14%
3 Years21%
5 Years27%
TTM17%
PAT CAGR
1 Year30%
3 Years22%
5 Years38%
TTM20%
Avg. ROCE
1 Year21%
3 Years20%
5 Years19%
TTM19%
CFO / EBITDA
1 Year34%
3 Years29%
5 Years44%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
234444171717171717
Reserves
ReservesCr
131323242628202736465964
Current Liabilities
Current LiabilitiesCr
2621304540383842435778117
Non Current Liabilities
Non Current LiabilitiesCr
4113355321005
Total Liabilities
Total LiabilitiesCr
464859767576778796120153202
Current Assets
Current AssetsCr
37384659575858657497129177
Non Current Assets
Non Current AssetsCr
91014171917202322232425
Total Assets
Total AssetsCr
464859767576778796120153202
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
234444171717171717
Reserves
ReservesCr
131323242628202736465964
Current Liabilities
Current LiabilitiesCr
2621304540383842435778117
Non Current Liabilities
Non Current LiabilitiesCr
4113355321005
Total Liabilities
Total LiabilitiesCr
464859767576778796120153202
Current Assets
Current AssetsCr
37384659575858657497129177
Non Current Assets
Non Current AssetsCr
91014171917202322232425
Total Assets
Total AssetsCr
464859767576778796120153202

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-4-3551-1168256
Investing Cash Flow
Investing Cash FlowCr
0-3-5-4-3-17-2-7-3-3-5
Financing Cash Flow
Financing Cash FlowCr
36-1-1318-6-20-1-1
Net Cash Flow
Net Cash FlowCr
-10-100-10-20-111
Free Cash Flow
Free Cash FlowCr
-4-432-1-2898221
CFO To PAT
CFO To PAT%
-352.0-197.6417.7314.859.3-436.7121.8112.829.448.544.8
CFO To EBITDA
CFO To EBITDA%
-108.7-80.3146.4178.934.0-215.879.984.918.932.634.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-4-3551-1168256
Investing Cash Flow
Investing Cash FlowCr
0-3-5-4-3-17-2-7-3-3-5
Financing Cash Flow
Financing Cash FlowCr
36-1-1318-6-20-1-1
Net Cash Flow
Net Cash FlowCr
-10-100-10-20-111
Free Cash Flow
Free Cash FlowCr
-4-432-1-2898221
CFO To PAT
CFO To PAT%
-352.0-197.6417.7314.859.3-436.7121.8112.829.448.544.8
CFO To EBITDA
CFO To EBITDA%
-108.7-80.3146.4178.934.0-215.879.984.918.932.634.5

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40353041139620409432271154
Price To Earnings
Price To Earnings
33.022.518.616.029.085.949.342.720.711.2
Price To Sales
Price To Sales
0.70.40.30.31.14.42.82.91.30.6
Price To Book
Price To Book
1.51.31.01.33.814.27.86.93.61.9
EV To EBITDA
EV To EBITDA
14.717.114.410.320.465.432.329.716.910.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.524.321.313.217.019.320.819.618.121.119.519.5
OPM
OPM%
5.57.45.72.83.24.36.16.88.99.98.36.9
NPM
NPM%
1.73.02.01.61.82.14.05.25.76.76.35.3
ROCE
ROCE%
9.48.68.87.77.89.714.520.220.119.221.118.6
ROE
ROE%
7.79.94.65.65.58.013.216.515.816.217.417.0
ROA
ROA%
2.53.42.02.12.23.46.28.38.68.48.66.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40353041139620409432271154
Price To Earnings
Price To Earnings
33.022.518.616.029.085.949.342.720.711.2
Price To Sales
Price To Sales
0.70.40.30.31.14.42.82.91.30.6
Price To Book
Price To Book
1.51.31.01.33.814.27.86.93.61.9
EV To EBITDA
EV To EBITDA
14.717.114.410.320.465.432.329.716.910.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.524.321.313.217.019.320.819.618.121.119.519.5
OPM
OPM%
5.57.45.72.83.24.36.16.88.99.98.36.9
NPM
NPM%
1.73.02.01.61.82.14.05.25.76.76.35.3
ROCE
ROCE%
9.48.68.87.77.89.714.520.220.119.221.118.6
ROE
ROE%
7.79.94.65.65.58.013.216.515.816.217.417.0
ROA
ROA%
2.53.42.02.12.23.46.28.38.68.48.66.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr202198177154151151132
Close PriceClose₹160.7067.20161.7018.5492.00255.24114.87
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE0.282.7233.4111.249.4720.1317.56
Price To SalesPS3.122.516.980.591.270.930.51
RevenueRevenueCr657925259118162259
Revenue Growth TTMRev Gr TTM%-14.9%3.4%50.8%7.5%24.2%26.0%
PAT Growth TTMPAT Gr TTM%421.4%-29.6%20.1%16.4%387.4%-31.9%
Market CapitalizationMkt CapCr202198177154151151132
Close PriceClose₹160.7067.20161.7018.5492.00255.24114.87
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE0.282.7233.4111.249.4720.1317.56
Price To SalesPS3.122.516.980.591.270.930.51
RevenueRevenueCr657925259118162259
Revenue Growth TTMRev Gr TTM%-14.9%3.4%50.8%7.5%24.2%26.0%
PAT Growth TTMPAT Gr TTM%421.4%-29.6%20.1%16.4%387.4%-31.9%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Load More
Interviews